In a groundbreaking development for cardiac healthcare in India, doctors at a leading Delhi hospital successfully implanted the country’s first dual-chamber leadless pacemaker in an 83-year-old patient on October 7, 2025. This advanced procedure marks a significant stride toward minimally invasive heart rhythm management, offering new hope for patients with slow or irregular heartbeats.
Key Findings:
The dual-chamber leadless pacemaker represents a major innovation beyond traditional pacemaker devices, which rely on leads or wires to regulate heart rhythms. This new device eliminates the risks associated with leads, such as infection and mechanical failure. The implanted pacemaker helps synchronize electrical signals in both the heart’s atrium and ventricle chambers, optimizing heart function for patients with complex arrhythmias.
Expert Commentary:
Dr. Aparna Jaswal, Director of Cardiac Pacing and Electrophysiology at Fortis Escorts Heart Institute (FEHI) in Delhi, underscored the importance of this procedure. “Leadless pacemakers reduce complications and improve patient comfort, especially in elderly patients who may not tolerate traditional devices well,” she said. “This advancement aligns with global standards and enhances treatment options in India.”
Context and Background:
Traditional pacemakers require leads to connect the pulse generator to the heart, which can pose challenges, especially in elderly or frail patients. Leadless pacemakers, first introduced globally in the late 2010s, have gained acceptance for their minimally invasive implantation via catheter through the femoral vein. However, most leadless devices until now have been single-chamber, limiting their use in patients needing more complex dual-chamber pacing.
India has witnessed rapid advancements in cardiac care, including sophisticated procedures such as electrophysiology studies, radiofrequency ablation for arrhythmias, robotic-assisted cardiac surgery, and transcatheter valve replacements, broadening options for treating diverse heart conditions.
Implications for Public Health:
The introduction of dual-chamber leadless pacemakers can significantly impact public health by reducing procedure-related complications, shortening hospital stays, and enhancing recovery speed, especially in elderly populations. This technological evolution promises to improve quality of life and reduce healthcare costs associated with device-related infections and lead repairs.
Limitations and Counterarguments:
While the device offers clear advantages, it may not be suitable for all patients, including those with specific anatomical or electrical heart conditions. Additionally, long-term data on dual-chamber leadless pacemakers are still emerging, emphasizing the need for ongoing research and post-implantation monitoring to establish safety and efficacy fully.
Practical Implications:
For patients and healthcare providers, this development means a broader choice of safer, effective pacemaker therapy. Awareness of this option encourages early consultation for arrhythmia symptoms such as fatigue, dizziness, or palpitations, allowing timely intervention with potentially less invasive methods.
References:
-
The Week, “Doctors implant first dual-chamber leadless pacemaker in India in 83-yr-old patient,” October 7, 2025.